CAMBRIDGE, Mass., Sept. 06, 2016 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016 at 9:55 a.m. ET in New York City.

A live webcast of the presentation will be available on the Investors & Media section of the Editas website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following the presentation.
                                                       
About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The Company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

CONTACT: Media Contact 
Dan Budwick

Pure Communications, Inc.

(973) 271-6085 
[email protected]

Investor Contact
Jesse Baumgartner
Stern Investor Relations, Inc.
(212) 362-1200
[email protected]